Neuland Laboratories Limited has announced that the United States Food and Drug Administration ("US FDA") has inspected our Unit 3 manufacturing facility, located at Gaddapotharam village, Jinnaram, Sangareddy District, from 22nd to 26th of May 2023.
The inspection has been concluded with 3 observations (minor) given under form 483, which are relating to procedures. The Company has already initiated corrective and preventive actions for the observations and is confident of addressing the same to the satisfaction of the US FDA within the stipulated time.
Shares of Neuland Laboratories Limited was last trading in BSE at Rs. 2619.45 as compared to the previous close of Rs. 2795.30. The total number of shares traded during the day was 8946 in over 1768 trades.
The stock hit an intraday high of Rs. 2751.00 and intraday low of 2603.20. The net turnover during the day was Rs. 23966006.00.